Zymergen
Zymergen was a synthetic-biology and bio-manufacturing company founded in 2013 in Emeryville, California, that used machine learning and automation to engineer microbes and discover novel bio-based materials and molecules. It went public on NASDAQ in 2021 and was acquired by Ginkgo Bioworks in October 2022; the zymergen.com domain now 301-redirects to Ginkgo Bioworks. It was surfaced as a portfolio company of DCVC, Kindred Ventures, and Obvious Ventures and added to the API Evangelist network for enrichment. Enrichment found no public developer portal, API, documentation, or event surface — the company has no independent API footprint following the acquisition. This profile is retained as a portfolio/history record.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Zymergen the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Zymergen scores 6.8/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
How we profile Zymergen
Each block below is one kind of artifact we hold for Zymergen. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Zymergen — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API
Other 1
Properties that don't map to a standard resource type
← All providers · Data indexed from github.com/api-evangelist/zymergen · machine-readable index on apis.io